Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, NMDA subunit 3A (GluN3A) is a subunit of the N-methyl-D-aspartate (NMDA) receptor complex. It is part of the superfamily of glutamate-regulated ion channels that play critical roles in excitatory neurotransmission within the central nervous system. Unlike conventional NMDARs, GluN1/GluN3 receptors are activated exclusively by glycine and function as ligand-gated cation channels. GluN3A modulates NMDA receptor activity during development and is implicated in synapse formation and synaptic plasticity.
Ligand-gated ion channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA subunit 3A (GluN3A).